Hormone Restoration Therapy Compounding – Laboratory Training
Unlike other biological systems, the endocrine system is particularly individualized with notable differences in hormonal set points that vary
from person to person; what may be normal for one may be abnormal for another. Consequently, we see a high demand for personalised
hormone restoration therapeutic options that are tailored to individual biological needs. This includes, but is not limited to, alterations in
dosage strength, customised pharmaceutical combinations, and the use of dosage forms therapeutically beneficial to the niche area of
hormone restoration, notably transdermal creams and gels, oral troches, and slow-release capsules.
In this laboratory course, participants will learn how to optimize the efficiency and quality of their compounded hormone preparations by
practicing novel compounding techniques and implementing innovative technologies and equipment.
- Estradiol 0.4 mg/mL, Estriol 0.6 mg/mL Topical Cream*
- Liothyronine 20 µg Slow-Release Oral Capsules*
- Progesterone 75 mg Oral Troches*
Note: Formulas are subject to change.
* Drugs that are found on the National Institute for Occupational Safety and Health
(NIOSH) list of Antineoplastic and Other Hazardous Drugs in Healthcare Settings will
be replaced by non-hazardous drugs. Proper hazardous drug handling techniques
and the correct use of personal protective equipment will be covered.
DURATION: 4 HOURS
SHANNON BELLEVUE, BSc, MSc
Medical Editor Team Lead, LP3 Network
TAMMY NGUYEN BPHARM, MPS
Compounding Pharmacist, MEDISCA Australia
Disclosure: MEDISCA Australia Employee
JENNIFER CLARE, BSc
Laboratory Facilitator, LP3 Network
Senior Technical Support Service Representative,
MEDISCA Network Inc
Tammy Nguyen, BPharm
Compounding Pharmacist, MEDISCA Australia.
Rebecca O’Grady, BPharm, GradCertPharmPrac
Technical Support Services Representative, MEDISCA Australia.
Patricia Ullmann, BPharm
Training and Support Services Manager, MEDISCA Australia.
Activity material is Copyright© 2008-2019 LP3 Network Inc.
Full attendance and participation is required to receive a Certificate of Attainment.
DECLARATIONS AND DISCLOSURES
This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist
with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with
MEDISCA AUSTRALIA ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.
An unrestricted educational grant has been provided by MEDISCA Inc. toward the purchase of electromechanical equipment, reusable
and disposable devices, protective and safety supplies, and chemicals specific to compounded medications prepared during laboratory
Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense
of the activity participant.
CANCELLATION AND REFUND POLICY
A written request must be sent to MEDISCA Australia requesting a ‘Cancellation without Transfer’ to an alternate live activity event date. If
cancellation occurs at greater than or equal to 31 days from the live activity event date, then the registrant will receive a 75% refund; 15-30
days is a 50% refund; and less than or equal to 14 days will result in no refund.
The transfer policy is only in effect if requested less than or equal to 15 days post original live activity event date. Failure to submit the
“Transfer Request” within 15 days post original live activity event date will default to the “Cancellation and Refund Policy”. The transfer
policy can only be applied one (1) time. Transfer to a new live activity event date must be within the current calendar year. Failure to attend
the new live activity event will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to
approval by MEDISCA Australia based on the number of available seats within the selected live activity event.